NASDAQ:BCTX
BriaCell Therapeutics Corp. Stock Company Profile
$1.43
-0.0700 (-4.67%)
At Close: May 23, 2024
Information
Bellevue Centre, Suite 300 235 West 15th Street
West Vancouver BC V7T 2X1
604 921 1810
www.briacell.com
Industry: Biotechnology
Sector: Healthcare
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
